Hyperuricemia
📧 Sign up to get email alerts when something new happens for Hyperuricemia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2013-06-11Clinical Trial Update: Safety, Tolerability and Pharmacokinetic/Pharmacodynamic Characteristics of LC350189 [Phase 1]
Phase 1 study of the investigational agent LC350189 in hyperuricemia and gout assessing safety, tolerability, and pharmacokinetic/pharmacody…
-
FDA approval · 2013-05-06FDA Approved: ALLOPURINOL — Original Application (Accord Healthcare Inc.)
FDA approved Accord Healthcare's original application for the generic drug allopurinol. Allopurinol is used to treat gout and to lower uric …
-
CLINICAL_TRIALS trial_result · 2013-04-25Clinical Trial Update: Effects of Green Tea on Level of Serum Uric Acid in Healthy Individuals [NA]
A completed clinical trial investigated whether green tea affects serum uric acid levels in healthy individuals. The study relates to hyperu…
-
FDA approval · 2012-11-01FDA Approved: ULORIC — Supplemental Application (Takeda Pharmaceuticals America, Inc.)
The FDA approved a supplemental application for ULORIC (febuxostat) from Takeda Pharmaceuticals America, Inc.
-
CLINICAL_TRIALS trial_result · 2012-09-03Clinical Trial Update: Lowering Serum Uric Acid to Prevent Acute Kidney Injury [Phase 2]
Phase 2 clinical trial evaluating whether lowering serum uric acid can prevent acute kidney injury.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2012-03-07Clinical Trial Update: Rasburicase for the Treatment/Prevention of Hyperuricemia in Adult Patients With Relapsing Aggressive Non Hodgkin's Lymphoma [Phase 2]
Phase 2 trial evaluating rasburicase for treatment/prevention of hyperuricemia in adults with relapsing aggressive non-Hodgkin lymphoma; sta…
-
CLINICAL_TRIALS trial_result · 2012-01-27Clinical Trial Update: Study of Levotofisopam 50 mg Three Times a Day (TID) Administered for 7 Days on Hyperuricemia and Gout [Phase 2]
A Phase 2 clinical trial evaluating Levotofisopam 50 mg three times daily for 7 days in patients with hyperuricemia and gout. The study stat…
-
FDA approval · 2011-01-28FDA Approved: ULORIC — Supplemental Application (Takeda Pharmaceuticals America, Inc.)
The FDA approved a supplemental application for ULORIC (febuxostat) submitted by Takeda Pharmaceuticals America, Inc. This notice indicates …
-
CLINICAL_TRIALS trial_result · 2011-01-06Clinical Trial Update: Study of Tranilast Alone or in Combination With Allopurinol in Subjects With Hyperuricemia [Phase 2]
A Phase 2 clinical trial evaluating tranilast alone or in combination with allopurinol in individuals with gout and hyperuricemia has comple…
-
CLINICAL_TRIALS trial_result · 2011-01-06Clinical Trial Update: Study of Tranilast Alone or in Combination With Febuxostat in Patients With Hyperuricemia [Phase 2]
A Phase 2 clinical trial evaluating tranilast alone or in combination with febuxostat in patients with gout and hyperuricemia has completed.
-
CLINICAL_TRIALS trial_result · 2011-01-06Clinical Trial Update: Tranilast Plus Allopurinol in Patients With Moderate to Severe Gout (TAnGO) [Phase 2]
Phase 2 trial evaluating tranilast in combination with allopurinol for moderate to severe gout with hyperuricemia has completed.
-
CLINICAL_TRIALS trial_result · 2010-11-29Clinical Trial Update: A Clinical Double Blind, Randomized Study of the Efficacy of Hyperuricemia Treatment With Anserine Product. [Phase 2]
Phase 2 randomized, double-blind trial evaluating the efficacy of an Anserine product for treating hyperuricemia.
-
CLINICAL_TRIALS trial_result · 2010-09-01Clinical Trial Update: Prednisone for Heart Failure Patients With Hyperuricemia [Phase 4]
A Phase 4 clinical trial evaluating prednisone in patients with heart failure and hyperuricemia has completed. The study was sponsored by He…
-
CLINICAL_TRIALS trial_result · 2010-07-09Clinical Trial Update: The Role Of Fructose and Uric Acid In the Development of Obesity and Metabolic Syndrome [NA]
Completed clinical trial evaluating the role of fructose and uric acid in the development of obesity and metabolic syndrome.
-
CLINICAL_TRIALS trial_result · 2010-02-23Clinical Trial Update: Safety and Efficacy Study of Intravenous Uricase-PEG 20 [Phase 1]
This Phase 1 trial evaluates the safety and preliminary efficacy of intravenous Uricase-PEG 20 for treating gout and hyperuricemia.
-
CLINICAL_TRIALS trial_result · 2009-12-31Clinical Trial Update: Rasburicase Versus Allopurinol in Tumor Patients at Risk for Hyperuricemia and Tumor Lysis Syndrome [Phase 3]
Phase 3 trial comparing rasburicase to allopurinol in cancer patients at risk for hyperuricemia and tumor lysis syndrome has completed with …
-
CLINICAL_TRIALS trial_result · 2009-12-24Clinical Trial Update: Safety and Efficacy Study of Intramuscular Uricase-PEG 20 [Phase 1]
This update reports on a Phase 1 safety and efficacy study of intramuscular Uricase-PEG 20 for gout and hyperuricemia. The study assesses pr…
-
CLINICAL_TRIALS trial_result · 2009-10-19Clinical Trial Update: Allopurinol in Chronic Heart Failure [Phase 4]
A Phase 4 clinical trial evaluating allopurinol in patients with chronic heart failure (and hyperuricemia) has completed. The document notes…
-
CLINICAL_TRIALS trial_result · 2009-10-02Clinical Trial Update: Rasburicase as a Uricolytic Therapy for Hyperuricemia in Patients With Leukemia or Lymphoma [Phase 2]
Phase 2 trial results evaluate rasburicase as a uricolytic therapy to treat hyperuricemia in patients with leukemia or lymphoma.
-
CLINICAL_TRIALS trial_result · 2009-09-25Clinical Trial Update: Rasburicase in Tumor Lysis Syndrome [Phase 4]
Phase 4 trial update indicating completion of rasburicase studies for tumor lysis syndrome with associated hyperuricemia.
-
CLINICAL_TRIALS trial_result · 2009-09-22Clinical Trial Update: The Effect of Uric Acid Decrement on Endothelial Function in Patients With Chronic Renal Failure [NA]
A completed clinical trial evaluating whether lowering uric acid improves endothelial function in patients with chronic kidney disease.
-
CLINICAL_TRIALS trial_result · 2009-07-16Clinical Trial Update: Magnetic Resonance Imaging in Subjects With Gouty Tophi
Takeda-sponsored clinical trial results assess magnetic resonance imaging (MRI) in subjects with gouty tophi and hyperuricemia.
-
CLINICAL_TRIALS trial_result · 2009-03-30Clinical Trial Update: Rasburicase for Hyperuricemia [Phase 2]
This clinical trial update reports the completion of a Phase 2 study of rasburicase for hyperuricemia.
-
FDA approval · 2009-02-13FDA Approved: ULORIC — Original Application (Takeda Pharmaceuticals America, Inc.)
FDA approved ULORIC (febuxostat) as the original application to treat hyperuricemia associated with gout by lowering serum uric acid levels.…
-
FDA approval · 2009-01-23FDA Approved: ALLOPURINOL — Supplemental Application (Actavis Pharma, Inc.)
The FDA approved a supplemental application for allopurinol from Actavis Pharma, updating the existing NDA.